Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

C.-M. Tai(National Chung Cheng University), Noriyuki Kasahara(University of California, San Francisco), Eric J. Sorscher(Emory University), William B. Parker(Io Therapeutics (United States)), Christopher R. Logg(University of California, Los Angeles), Jeong S. Hong(University of Alabama at Birmingham), Y-H Lai(National Chung Cheng University), Yufen Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenxue Wang(Zero to Three), Thomas C. Chen(Keck Hospital of USC)
Cancer Gene Therapy
May 14, 2010
Cited by 42


Related Papers